DCM Shriram Industries’ demerger is structurally value-unlocking in intent, but still at the regulatory-approval stage, with both clear positives and important risks to keep in mind.

1. Current status (as of Dec 2025)

- The Board approved a Composite Scheme of Arrangement on 14 Nov 2023. It involves:

- Merger of Lily Commercial Pvt Ltd (promoter investment company) into DCM Shriram Industries Ltd (DCMSR).

- Subsequent demerger of the Chemical and Rayon (industrial fibres + defence/engineering) businesses into two wholly owned subsidiaries:

- DCM Shriram Fine Chemicals Ltd (DSFCL) – chemicals

- DCM Shriram International Ltd (DCM International) – rayon / industrial fibres / defence & engineering (indianexpress.com)

- Appointed date for the restructuring is 1 April 2023, but accounting effect has NOT yet been given; the scheme is still pending approvals.

- The scheme has been cleared by BSE & NSE under listing regulations, approved by shareholders/unsecured creditors, and has been filed with NCLT, New Delhi (23 Oct 2024); as per the latest results notes (up to Aug 2025), it is still awaiting NCLT sanction. (trendlyne.com)

2. Post‑demerger structure (proposed)

Once effective, you effectively get three focused companies for every one share held today:

- DCM Shriram Industries Ltd (residual listed entity)

- Will retain Sugar + Alcohol + Power only.

- DCM Shriram Fine Chemicals Ltd (to be listed)

- Will house the fine chemicals business.

- DCM Shriram International Ltd (to be listed)

- Will house rayon / industrial fibres + defence & engineering projects. (in.marketscreener.com)

As per the scheme/valuation reports, the share entitlement is 1:1:1 – illustratively, for every 1 share of DCMSR, shareholders are expected to receive 1 share each in DSFCL and DCM International, in addition to the existing DCMSR share that remains the sugar company (subject to final approved scheme details and listing process). (in.marketscreener.com)

3. Strategic positives of the demerger (analytical view)

1) Clearer business profiles

- Today’s DCMSR combines:

- A cyclical, regulated sugar business (with distillery & power), and

- Higher‑margin, more stable industrial fibres and chemicals. (indianexpress.com)

- The demerger separates these into distinct vehicles, which typically helps:

- Sharper capital allocation,

- Industry‑specific investors (sugar vs speciality chemicals vs industrial fibres/defence),

- Better benchmarking vs pure‑play peers.

2) Potential value unlocking / SOTP re‑rating

- External analyses have highlighted that chemicals and rayon/industrial fibres carry higher margins and better return profiles than sugar, yet the combined company often trades more like a cyclical sugar stock. (indianexpress.com)

- Example (not a recommendation): A special‑situations investor may:

- Assign conservative multiples to:

- Sugar (low multiple, cyclical/regulatory)

- Chemicals & fibres/defence (higher multiple, steadier earnings)

- Compare this sum‑of‑the‑parts (SOTP) with the current market capitalisation of DCMSR to see if the demerger discount is attractive.

3) Promoter‑holding simplification

- Merger of Lily and consolidation of several promoter investment companies is aimed at removing layers and simplifying promoter holding—this generally improves transparency and can aid long‑term governance/succession planning. (mnacritique.mergersindia.com)

4) Listing of two new platforms

- Separate listings for DSFCL (chemicals) and DCM International (fibres/defence) could, over time,

- Improve price discovery for those businesses,

- Allow independent fund‑raising / partnerships,

- Attract sector‑specific institutional investors.

4. Key risks / watch‑outs

1) Regulatory and timeline risk

- As of the latest disclosures, the scheme is still before NCLT; actual effective date, record date, and listing timelines for the two resultant companies are uncertain and can slip. (trendlyne.com)

2) Sugar‑only residual company = higher earnings volatility

- Post‑demerger, the listed DCMSR will be smaller and more concentrated in sugar, losing the stabilising effect of chemicals and rayon. (indianexpress.com)

- That typically implies:

- More earnings volatility (linked to sugar cycle, cane price policy, export/import policy),

- Potentially lower valuation multiples vs the current blended profile.

3) Execution & listing risk in the new entities

- DSFCL and DCM International will initially be smaller, newly listed entities; typical issues:

- Liquidity constraints in the early months of listing,

- Market may initially undervalue or over‑discount these names until track record as stand‑alone entities is visible.

4) Institutional behaviour

- LIC has reduced its stake in DCMSR over 2021–2024, which shows that even large institutions may be repositioning ahead of or during the restructuring. This is not necessarily a negative on fundamentals but indicates portfolio‑level rebalancing and timeline uncertainty. (indianchemicalnews.com)

5. How an investor might approach it (example framework, not advice)

- Check latest filings on BSE / NSE and the company website for:

- NCLT order status,

- Final approved scheme text,

- Record date and listing approvals for DSFCL & DCM International.

- Build a simple SOTP (illustrative only):

- Use recent segment revenues/margins for sugar, chemicals and fibres,

- Apply conservative peer‑based multiples,

- Compare SOTP vs current DCMSR market cap to gauge whether there is still a meaningful “demerger discount”.

- Re‑evaluate post‑listing of the two resultant companies: actual listing multiples, liquidity, and management commentary will materially influence long‑term attractiveness.

In summary, structurally the demerger is designed to unlock value and sharpen business focus, but it is still in the implementation/approval phase, and brings sugar‑concentration risk into the residual listed company and execution/listing risk in the two demerged entities. Any decision should be based on your risk appetite, time horizon, and independent assessment of SOTP vs current pricing.

If you have any further queries, please connect with us on 022-6290-10141 (Timings : 09.00 AM to 05.00 PM) or you can email us on info@cniinfoxchange.com